Parallel Proceedings Think Tank: Winning Strategies for Navigating the District Court and Inter Parte Review (IPR)

April 27, 2022 3:15pm

Peter Waibel
Head, US Patent Litigation
Novartis Pharmaceuticals Corporation

Dan Minion

Eric W. Dittmann
Partner and Global Vice-Chair, Intellectual Property
Paul Hastings LLP

Kathleen B. Carr
McCarter & English, LLP


Gerald J. Flattmann, Jr.
King & Spalding LLP

  • Developing new strategies for parallel proceedings in the District Courts and PTAB in view of a single standard
    • Weighing the future of parallel proceedings in view of a single standard adoption
  • Considering the takeaways from the patent challenger’s perspective in addition to the patentee perspective
  • Devising strategies relative to the filing of an IPR or similar proceeding during the pendency of District Court litigation
  • Formulating strategies based on type of pharmaceutical patent
  • Establishing jurisdiction at the PTAB
    • Special considerations for ex-U.S. parties
  • Developing sound discovery strategies relative to dual proceedings
  • Evaluating chances of getting a stay granted in the District Court
  • Managing experts and use of experts in both forums
  • Appealing decisions in both forums